The following is a summary of the KP Tissue Inc. (KPTSF) Q1 2024 Earnings Call Transcript:

Financial Performance:

• KP Tissue reported a 6.3% increase in revenue for Q1 2024, largely due to a higher sales volume and favorable sales mix.

• Canadian revenues saw a modest increase of 2.1%, while US revenues improved significantly by 12.1%.

• Adjusted EBITDA was up significantly by 34.3% year-over-year to $67.1 million, largely thanks to higher sales volume, improved sales mix, lower pulp prices, and favorable freight costs.

• The company's net income for Q1 2024 was $9 million, a major improvement over the net loss of $49.3 million in Q1 2023.

Business Progress:

• KP Tissue has consolidated its leadership position in the facial tissue market and is amping up investment in marketing, added manufacturing capacity, and product innovation.

• The company's Away-From-Home business delivered strong performance in Q1.

• The new facial tissue line in Sherbrooke is now producing high-quality, saleable products.

• Projected to commence in Q4 2024, the new paper machine construction is on track.

• KP Tissue expects the adjusted EBITDA for Q2 2024 to closely mirror that of Q1 2024, despite expected increases in pulp prices.

• Further investments are being made in the organization, culture, and brands to foster both present and future growth.

More details: KP TISSUE INC IR

Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.